Invesaro

Stocks Comparison

Davita vs Charming Medical: revenue, profit, margins and growth compared

Davita brought in $13.6B of revenue in fiscal 2025, Charming Medical $4.8M in fiscal 2026. Revenue changed by +6.5% at Davita and -22.7% at Charming Medical on the year before, so Davita grew faster. Davita kept 5.5% of its revenue as net profit, Charming Medical -0.5%. Free cash flow was $1.3B at Davita and -$1.6M at Charming Medical.

Side by side, latest fiscal year

DVAMCTA
Fiscal year endedFY2025 (December 31, 2025)FY2026 (March 31, 2026)
Revenue$13.6B$4.8M
Revenue growth+6.5%-22.7%
Net income$746.8M-$22.6K
Net margin5.5%-0.5%
Free cash flow$1.3B-$1.6M
Free cash flow margin9.6%-32.4%
Earnings per share (diluted)$9.84$0.00
Cash$676.4M$4.7M
Debt$10.3B$185.8K
Price to earnings18.1n/a
Market value$11.4Bn/a
Dividend yieldn/an/a
Rank by revenue in sector#37 of 646 · Health care#509 of 646 · Health care

Over the years

Revenue
DVA FY2018: $11.4BDVA FY2019: $11.4BDVA FY2020: $11.6BDVA FY2021: $11.6BDVA FY2022: $11.6BDVA FY2023: $12.1BDVA FY2024: $12.8BDVA FY2025: $13.6BMCTA FY2024: $6MMCTA FY2026: $6.2MMCTA FY2026: $4.8MFY18FY19FY20FY21FY22FY23FY24FY25FY26
DVA $13.6BMCTA $4.8M
Net income
DVA FY2018: $159.4MDVA FY2019: $811MDVA FY2020: $773.6MDVA FY2021: $978.5MDVA FY2022: $560.4MDVA FY2023: $691.5MDVA FY2024: $936.3MDVA FY2025: $746.8MMCTA FY2024: $777.8KMCTA FY2026: $1.2MMCTA FY2026: -$22.6KFY18FY19FY20FY21FY22FY23FY24FY25FY26
DVA $746.8MMCTA -$22.6K
Net margin
DVA FY2018: 1.4%DVA FY2019: 7.1%DVA FY2020: 6.7%DVA FY2021: 8.4%DVA FY2022: 4.8%DVA FY2023: 5.7%DVA FY2024: 7.3%DVA FY2025: 5.5%MCTA FY2024: 12.9%MCTA FY2026: 19.3%MCTA FY2026: -0.5%FY18FY19FY20FY21FY22FY23FY24FY25FY26
DVA 5.5%MCTA -0.5%
Revenue growth
DVA FY2019: -0.1%DVA FY2020: +1.4%DVA FY2021: +0.6%DVA FY2022: -0.1%DVA FY2023: +4.6%DVA FY2024: +5.6%DVA FY2025: +6.5%MCTA FY2026: +3.4%MCTA FY2026: -22.7%FY19FY20FY21FY22FY23FY24FY25FY26
DVA +6.5%MCTA -22.7%
Free cash flow
DVA FY2018: $784.5MDVA FY2019: $1.3BDVA FY2020: $1.3BDVA FY2021: $1.3BDVA FY2022: $961.1MDVA FY2023: $1.5BDVA FY2024: $1.5BDVA FY2025: $1.3BMCTA FY2024: $84.8KMCTA FY2026: $138.4KMCTA FY2026: -$1.6MFY18FY19FY20FY21FY22FY23FY24FY25FY26
DVA $1.3BMCTA -$1.6M

Fiscal years as each company reports them; the two may end in different months.

Questions about Davita and Charming Medical

Which is bigger by revenue, Davita or Charming Medical?

Davita is bigger by revenue: $13.6B in fiscal 2025, against $4.8M for Charming Medical in fiscal 2026.

Which keeps more of its revenue as profit, Davita or Charming Medical?

Davita had a net margin of 5.5% in fiscal 2025; Charming Medical had -0.5% in fiscal 2026.

Which grew revenue faster, Davita or Charming Medical?

In their latest fiscal years revenue changed by +6.5% at Davita and -22.7% at Charming Medical.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies